Inicio/Acciones/SXTPW

SXTPW

USD

60 Degrees Pharmaceuticals Inc. Warrant

$0.065+0.015 (29.225%)

Precio en Tiempo Real

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$0.050

Máximo

$0.065

Mínimo

$0.050

Volumen

0.01M

Fundamentos de la Empresa

Estadísticas de Negociación

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $0.05Actual $0.065Máximo $0.065

Noticias Relacionadas

15 oct 2025 · 11:14

GlobeNewswire

60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study

Breakthrough Therapy Designation request has been submitted to FDACompany to request a Type B meeting with FDA in early 2026 to discuss requirements for a supplementary New Drug Application (sNDA)Results obtained using

60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study

9 oct 2025 · 11:04

GlobeNewswire

60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study

Company engaged patients diagnosed with chronic babesiosis via social media in a nationwide naming competitionA $5K donation from the Company was split between ILADEF and GLA to recognize the winning nameB-FREE, a Phase